Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Wang, Huia | Tan, Lana; b; c; * | Wang, Hui-Fub | Liu, Yinga | Yin, Rui-Huab | Wang, Wen-Yingb | Chang, Xiao-Longb | Jiang, Tengd | Yu, Jin-Taib; c; d; e; *
Affiliations: [a] Department of Neurology, Qingdao Municipal Hospital, Dalian Medical University, China | [b] Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, China | [c] Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, China | [d] Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China | [e] Memory and Aging Center, Deparment of Neurology, University of California, San Francisco, USA
Correspondence: [*] Correspondence to: Lan Tan, MD, PhD, Department ofNeurology, Qingdao Municipal Hospital, School of Medicine,Qingdao University, No.5 Donghai Middle Road, Qingdao, Shandong Province 266071, China. E-mail: [email protected]
Correspondence: [*] Correspondence to:Jin-Tai Yu, MD, PhD, Deparment of Neurology, University of California, San Francisco, 675 Nelson Rising Lane, Suite 190, Box 1207, San Francisco, CA 94158, USA. E-mails: [email protected] or E-mail: [email protected]
Abstract: Background: The application of non-invasive proton magnetic resonance spectroscopy (1H-MRS) could potentially identify changes in cerebral metabolites in the patients with Alzheimer’s disease (AD). However, whether these metabolites can serve as biomarkers for the diagnosis of AD remains unclear. Objective: Using meta-analysis, we aimed to investigate the patterns of cerebral metabolite changes in several cerebral regions that are strongly associated with cognitive decline in AD patients. Methods: Using Hedges’ g effect size, a systematic search was performed in PubMed, Cochrane Library, Ovid, Embase, and EBSCO, and 38 studies were integrated into the final meta-analysis. Results: According to the observational studies, N-acetyl aspartate (NAA) in AD patients was significantly reduced in the posterior cingulate (PC) (effect size (ES) =−0.924, p < 0.005) and bilateral hippocampus (left hippocampus: ES =−1.329, p < 0.005; right hippocampus: ES =−1.287, p < 0.005). NAA/Cr (creatine) ratio decreased markedly in the PC (ES =−1.052, p < 0.005). Simultaneously, significant elevated myo-inositol (mI)/Cr ratio was found not only in the PC but also in the parietal gray matter. For lack of sufficient data, we failed to elucidate the efficacy of pharmacological interventions with the metabolites changes. Conclusion: The available data indicates that NAA, mI, and the NAA/Cr ratio might be potential biomarkers of brain dysfunction in AD subjects. Choline (Cho)/Cr and mI/NAA changes might also contribute toward the diagnostic process. Thus, large, well-designed studies correlated with cerebral metabolism are needed to better estimate the cerebral extent of alterations in brain metabolite levels in AD patients.
Keywords: Alzheimer’s disease, choline, creatine, glutamate and glutamine, magnetic resonance spectroscopy, meta-analysis, myo-inositol, N-acetyl aspartate
DOI: 10.3233/JAD-143225
Journal: Journal of Alzheimer's Disease, vol. 46, no. 4, pp. 1049-1070, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]